SCHEMBL19338002

SCHEMBL19338002

CC1CCCC(=N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24171958 0.83
SCHEMBL18469256 0.80
SCHEMBL21669671 0.79 NOS3 (0.37)
SCHEMBL22539818 0.72 NOS3 (0.39)
SCHEMBL23678896 0.72
SCHEMBL3139956 0.70
SCHEMBL1402674 0.70
SCHEMBL24208193 0.70 NOS3 (0.31)
SCHEMBL22539633 0.70 CA1 (0.39)
SCHEMBL23253426 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159455-A1 DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS SENSORIUM THERAPEUTICS, INC. 2023-05-25 US disclosed
WO-2020264495-A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS SAGE THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
EP-2691997-B1 COMPLEXATION OF LOW-MOLECULAR SEMICONDUCTORS FOR THE APPLICATION AS AN EMITTER COMPLEX IN ORGANIC LIGHT-EMITTING ELECTROCHEMICAL CELLS (OLEECS) OSRAM OLED GMBH (DE) 2017-09-13 EP disclosed